X4 Pharmaceuticals (XFOR) EBIT Growth (1y) (2018 - 2025)
X4 Pharmaceuticals (XFOR) EBIT Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 2,150.96% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.14 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | 145.20% |
| 9 | Revolution Medicines | 37.46 Bn | 37.46 Bn | - | - |
| 10 | X4 Pharmaceuticals | 167.48 Mn | -49.57 Mn | 2.20 Mn | 33.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 33.64% |
| Sep 30, 2025 | 20.26% |
| Jun 30, 2025 | -136.89% |
| Mar 31, 2025 | 74.68% |
| Dec 31, 2024 | -41.73% |
| Sep 30, 2024 | -26.77% |
| Jun 30, 2024 | 375.54% |
| Mar 31, 2024 | -27.25% |
| Dec 31, 2023 | 1.48% |
| Sep 30, 2023 | -35.03% |
| Jun 30, 2023 | -25.45% |
| Mar 31, 2023 | -37.78% |
| Dec 31, 2022 | 11.97% |
| Sep 30, 2022 | -5.41% |
| Jun 30, 2022 | -8.28% |
| Mar 31, 2022 | -18.58% |
| Dec 31, 2021 | -64.57% |
| Sep 30, 2021 | -12.60% |
| Jun 30, 2021 | -29.60% |
| Mar 31, 2021 | -69.51% |